Stockscreener 앱 받기
29.96
1.19%
-0.36
시간 외 거래:
29.99
0.03
+0.10%
Harmony Biosciences Holdings Inc 주식(HRMY)의 최신 뉴스
Harmony Biosciences Holdings Inc (HRMY) Q1 2025 Earnings Report Preview: What to Look For - GuruFocus
Raymond James Financial Inc. Makes New $1.30 Million Investment in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
Wells Fargo & Company MN Reduces Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
Harmony Biosciences Holdings Inc expected to post earnings of 59 cents a shareEarnings Preview - TradingView
(HRMY) Trading Signals - news.stocktradersdaily.com
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Receives Average Rating of “Buy” from Analysts - Defense World
Why Harmony Biosciences (HRMY) Could Beat Earnings Estimates Again - Yahoo Finance
H.C. Wainwright maintains $70 target on Harmony Biosciences stock By Investing.com - Investing.com India
Harmony Biosciences to Report First Quarter 2025 Financial Results on May 6, 2025 - BioSpace
H.C. Wainwright maintains $70 target on Harmony Biosciences stock - Investing.com Australia
Harmony Biosciences to Report First Quarter 2025 Financial Resul - GuruFocus
H.C. Wainwright Reiterates Buy Rating on Harmony Biosciences Holdings Inc. (HRMY) - StreetInsider
UBS Adjusts Price Target for Harmony Biosciences (HRMY) | HRMY S - GuruFocus
UBS Adjusts Price Target on Harmony Biosciences to $48 From $55, Maintains Buy Rating - marketscreener.com
Press Release Distribution & PR Platform - ACCESS Newswire
Harmony Biosciences (HRMY) Projected to Post Earnings on Tuesday - Defense World
First Week of June 20th Options Trading For Harmony Biosciences Holdings (HRMY) - Nasdaq
Is Weakness In Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects? - simplywall.st
BofA Cuts Price Target on Harmony Biosciences to $32 From $33 - marketscreener.com
Harmony Biosciences (HRMY) Faces Revised Price Target Amid Q1 Ch - GuruFocus
Invesco Ltd. Raises Stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
JAZZ vs. HRMY: Which Neuroscience Drugmaker Is the Stronger Play? - Zacks Investment Research
Harmony Biosciences Holdings, Inc. (HRMY) Investigation: Bronstei - NatLawReview.com
Russell Investments Group Ltd. Has $1.60 Million Stock Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
Harmony Biosciences Presents Positive Data on ZYN002 for Fragile X Syndrome - MSN
Geode Capital Management LLC Has $31.08 Million Stock Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
(HRMY) Technical Data - news.stocktradersdaily.com
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Shares Bought by JPMorgan Chase & Co. - Defense World
Franklin Resources Inc. Has $1.10 Million Stock Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
Lobbying Update: $45,000 of HARMONY BIOSCIENCES lobbying was just disclosed - Nasdaq
Harmony Biosciences Appoints Ron Philip to Board of Directors - MSN
Harmony Biosciences (NASDAQ:HRMY) Earns “Buy” Rating from HC Wainwright - Defense World
Breaking Down Harmony Biosciences Hldgs: 13 Analysts Share Their Views - Benzinga
Harmony Biosciences Presents Promising Open-Label Extension Data of ZYN002 in Fragile X Syndrome - BioSpace
Oppenheimer maintains Harmony Biosciences Outperform rating By Investing.com - Investing.com South Africa
Developmental and Epileptic Encephalopathies Market to Observe Stunning Growth During the Study Period (2020–2034) | DelveInsight - GlobeNewswire Inc.
Oppenheimer on Harmony Biosciences (HRMY): 'we remain pleased with WAKIX's 4Q24 performance' - StreetInsider
Bronstein, Gewirtz & Grossman, LLC Is Investigating Harmony Biosciences Holdings, Inc. (HRMY) And Encourages Shareholders to Connect - markets.businessinsider.com
Harmony Biosciences reports progress in Fragile X syndrome gel treatment - Investing.com
Harmony Biosciences reports progress in Fragile X syndrome gel treatment By Investing.com - Investing.com India
HRMY stock touches 52-week low at $27.87 amid market shifts By Investing.com - Investing.com South Africa
HRMY stock touches 52-week low at $27.87 amid market shifts - Investing.com India
Corebridge Financial Inc. Raises Stock Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
Vanguard Group Inc. Has $162.88 Million Stock Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - The AM Reporter
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Stock Holdings Increased by Vanguard Group Inc. - Defense World
Arrowstreet Capital Limited Partnership Has $10.21 Million Stock Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - The AM Reporter
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Given Average Rating of “Buy” by Analysts - The AM Reporter
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Given Consensus Recommendation of “Buy” by Analysts - Defense World
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Harmony Biosciences Holdings, Inc. (HRMY) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Harmony Biosciences Holdings, Inc. (HRMY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - markets.businessinsider.com
0.39%
3.66%
자본화:
|
볼륨(24시간):